{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:27:27Z","timestamp":1794302847303,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:40:20Z","timestamp":1785825620000},"page":"263-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In Vivo Microscopic Assessment of Ocular Surface Changes Induced By Antiglaucoma Medications"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-5341","authenticated-orcid":false,"given":"Blaze Ann C.","family":"Carbonell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Arthur Milhomens","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhith","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6029-733X","authenticated-orcid":false,"given":"Jerald","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando S.","family":"Ganasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa Z.","family":"Karslioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-7219","authenticated-orcid":false,"given":"Ken Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1617-1165","authenticated-orcid":false,"given":"Olivia L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ajo.2026.08.003_bib0001","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.003_bib0002","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mayocpiqo.2022.09.007","article-title":"Updates on the diagnosis and management of glaucoma","volume":"6","author":"Wagner","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ajo.2026.08.003_bib0003","article-title":"A comparative study on efficacy of fixed combination timolol\/brinzolamide versus travoprost monotherapy in drug-na\u00efve open-angle glaucoma patients","volume":"12","author":"Dixit","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.003_bib0004","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2026.08.003_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2023.1067942","article-title":"Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy","volume":"5","author":"Ruiz-Lozano","year":"2023","journal-title":"Front Toxicol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.003_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bjo.82.1.39","article-title":"Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers","volume":"82","author":"Baudouin","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.003_bib0007","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0300-1652.182071","article-title":"Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans","volume":"57","author":"Ilechie","year":"2016","journal-title":"Niger Med J"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.003_bib0008","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00061198-200312000-00008","article-title":"Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride","volume":"12","author":"Ishibashi","year":"2003","journal-title":"J Glaucoma"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.003_bib0009","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3109\/02713683.2010.489181","article-title":"Influence of benzalkonium chloride on Langerhans cells in corneal epithelium and development of dry eye in healthy volunteers","volume":"35","author":"Zhivov","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2026.08.003_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jtos.2020.05.012","article-title":"Correlation of corneal immune cell changes with clinical severity in dry eye disease: an in vivo confocal microscopy study","volume":"19","author":"Aggarwal","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2026.08.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4369750","article-title":"Corneal dendritic cell density is associated with subbasal nerve plexus features, ocular surface disease index, and serum vitamin D in evaporative dry eye disease","volume":"2016","author":"Shetty","year":"2016","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.003_bib0012","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00417-017-3680-3","article-title":"Correlation between corneal innervation and inflammation evaluated with confocal microscopy and symptomatology in patients with dry eye syndromes: a preliminary study","volume":"255","author":"Tepelus","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.003_bib0013","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000484632","article-title":"Assessment of corneal changes associated with topical antiglaucoma therapy using in vivo confocal microscopy","volume":"61","author":"Baghdasaryan","year":"2019","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.003_bib0014","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00003226-200105000-00008","article-title":"Morphology of corneal nerves using confocal microscopy","volume":"20","author":"Oliveira-Soto","year":"2001","journal-title":"Cornea"},{"issue":"Supplement 1","key":"10.1016\/j.ajo.2026.08.003_bib0015","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/ICO.0000000000000989","article-title":"Bilateral alterations in corneal nerves, dendritic cells, and tear cytokine levels in ocular surface disease","volume":"35","author":"Yamaguchi","year":"2016","journal-title":"Cornea"},{"issue":"14","key":"10.1016\/j.ajo.2026.08.003_bib0016","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1167\/iovs.16-20333","article-title":"In vivo distribution of corneal epithelial dendritic cells in patients with glaucoma","volume":"57","author":"Mastropasqua","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.003_bib0017","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1017\/S1431927621013969","article-title":"In vivo confocal microscopy of the corneal sub-basal nerve plexus in medically controlled glaucoma","volume":"28","author":"Agnifili","year":"2022","journal-title":"Microsc Microanal"},{"key":"10.1016\/j.ajo.2026.08.003_bib0018","first-page":"1","article-title":"Effects of long-term antiglaucoma eye drops on conjunctival structures: an in vivo confocal microscopy study","volume":"2015","author":"Zhu","year":"2015","journal-title":"J Ophthalmol"},{"issue":"21","key":"10.1016\/j.ajo.2026.08.003_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113114","article-title":"Corneal epithelial regeneration: old and new perspectives","volume":"23","author":"Nuzzi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2026.08.003_bib0020","article-title":"Elucidating the mechanism of corneal epithelial cell repair: unraveling the impact of growth factors","volume":"11","author":"Gong","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajo.2026.08.003_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/460483","article-title":"The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study","volume":"2014","author":"Kurna","year":"2014","journal-title":"J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.003_bib0022","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00061198-200312000-00007","article-title":"Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy","volume":"12","author":"Inoue","year":"2003","journal-title":"J Glaucoma"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.003_bib0023","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12325-013-0021-8","article-title":"Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface","volume":"30","author":"Lee","year":"2013","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.003_bib0024","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/bjo.84.11.1250","article-title":"Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone","volume":"84","author":"Shimazaki","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.003_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","article-title":"Corneal nerves: structure, contents and function","volume":"76","author":"M\u00fcller","year":"2003","journal-title":"Exp Eye"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.003_bib0026","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1167\/iovs.03-1067","article-title":"Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study","volume":"45","author":"Pisella","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.003_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1755-3768.1981.tb02999.x","article-title":"Corneal anaesthesia after topical treatment with timolol maleate. A case report","volume":"59","author":"Calissendorff","year":"1981","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.003_bib0028","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-9394(79)90675-5","article-title":"Corneal anesthesia after timolol maleate therapy","volume":"88","author":"Michael Van Buskirk","year":"1979","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.003_bib0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1990.6.85","article-title":"The effect of timolol, betaxolol, and placebo on corneal sensitivity in healthy volunteers","volume":"6","author":"Vogel","year":"1990","journal-title":"J Ocul Pharmacol"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.003_bib0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bjo.74.7.409","article-title":"Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity","volume":"74","author":"Weissman","year":"1990","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.003_bib0031","first-page":"639","article-title":"Novel characterization of MHC class II\u2013Negative population of resident corneal langerhans cell\u2013type dendritic cells","volume":"43","author":"Hamrah","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.003_bib0032","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/bjo.2004.053025","article-title":"Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection","volume":"89","author":"Kalapesi","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2026.08.003_bib0033","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1177\/112067210101102S03","article-title":"Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma","volume":"11","author":"Wheeler","year":"2001","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.003_bib0034","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/cells14040258","article-title":"Drug- and cell-type-specific effects of ROCK inhibitors as a potential cause of reticular corneal epithelial edema","volume":"14","author":"Schl\u00f6tzer-Schrehardt","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ajo.2026.08.003_bib0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/OPTH.S18849","article-title":"Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects","author":"Terai","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"10180","key":"10.1016\/j.ajo.2026.08.003_bib0036","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942600440X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942600440X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:03:50Z","timestamp":1794301430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942600440X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S000293942600440X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.003","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Microscopic Assessment of Ocular Surface Changes Induced By Antiglaucoma Medications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}